Amarin Corp Plc (AMRN)

[KCSVEN]

That's a good point, hard to find comparisons to this situation. Investors on these boards are all close to this and talk to people about it, seems everyone is aware of Vascepa, but the reality is the vast majority of people have no idea what it is. I randomly asked 20 people at work, not one knew what it was. I know small sample size and all but mainstream knowledge of Vascepa is low.


But also is the catch 22, once they get expanded label will need high cost marketing and sales blitz. Once date of FDA approval is mostly known, if GIA, they should be hiring more sales people months before approval.


Since no company has really gone through this exact situation very hard to judge what management should be accomplishing at this point in time.

If it does stay range bound here for the next 7 months with similar up and down volatility I can knock 7 bucks off my basis selling options so something to be hopeful for if a real long haul here.